Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Li Y, Takemura G, Kosai K, Yuge K, Nagano S, Esaki M, Goto K, Takahashi T, Hayakawa K, Koda M, Kawase Y, Maruyama R, Okada H, Minatoguchi S, Mizuguchi H, Fujiwara T, Fujiwara H. Li Y, et al. Among authors: kosai k. Circulation. 2003 May 20;107(19):2499-506. doi: 10.1161/01.CIR.0000065579.19126.B8. Epub 2003 Apr 14. Circulation. 2003. PMID: 12695295
Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, Koda M, Arai M, Misao Y, Lu C, Suzuki K, Goto K, Komada A, Takahashi T, Kosai K, Fujiwara T, Fujiwara H. Minatoguchi S, et al. Among authors: kosai k. Circulation. 2004 Jun 1;109(21):2572-80. doi: 10.1161/01.CIR.0000129770.93985.3E. Epub 2004 May 3. Circulation. 2004. PMID: 15123535
Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure.
Okada H, Takemura G, Kosai K, Li Y, Takahashi T, Esaki M, Yuge K, Miyata S, Maruyama R, Mikami A, Minatoguchi S, Fujiwara T, Fujiwara H. Okada H, et al. Among authors: kosai k. Circulation. 2005 May 17;111(19):2430-7. doi: 10.1161/01.CIR.0000165066.71481.8E. Epub 2005 May 2. Circulation. 2005. PMID: 15867170
Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy.
Esaki M, Takemura G, Kosai K, Takahashi T, Miyata S, Li L, Goto K, Maruyama R, Okada H, Kanamori H, Ogino A, Ushikoshi H, Minatoguchi S, Fujiwara T, Fujiwara H. Esaki M, et al. Among authors: kosai k. Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H1048-57. doi: 10.1152/ajpheart.01102.2007. Epub 2007 Dec 14. Am J Physiol Heart Circ Physiol. 2008. PMID: 18083897 Free article.
Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
Kondo T, Takemura G, Kosai K, Ohno T, Takahashi T, Esaki M, Goto K, Maruyama R, Murata I, Minatoguchi S, Fujiwara T, Fujiwara H. Kondo T, et al. Among authors: kosai k. Clin Exp Pharmacol Physiol. 2008 Nov;35(11):1288-93. doi: 10.1111/j.1440-1681.2008.04967.x. Epub 2008 May 23. Clin Exp Pharmacol Physiol. 2008. PMID: 18505441
Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure.
Okada H, Takemura G, Kosai K, Tsujimoto A, Esaki M, Takahashi T, Nagano S, Kanamori H, Miyata S, Li Y, Ohno T, Maruyama R, Ogino A, Li L, Nakagawa M, Nagashima K, Fujiwara T, Fujiwara H, Minatoguchi S. Okada H, et al. Among authors: kosai k. Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H616-26. doi: 10.1152/ajpheart.01147.2008. Epub 2009 Jan 16. Am J Physiol Heart Circ Physiol. 2009. PMID: 19151252 Free article.
207 results